Efficacy of Pethidine and Buprenorphine for Prevention and Treatment of Postanesthetic Shivering

Author(s):
Message:
Abstract:
Background
Postanesthetic shivering is a distressing postoperative complication. Pharmacological control is an effective method for treatment and prevention of postoperative shivering. Pethidine prevents or manages shivering far better than equianalgesic doses of other opioids. However, buprenorphine is an opioid with a similar structure to morphine but approximately 33 times more potent. This study aimed to assess and compare the effects of these two opioids in preventing post-anesthetic shivering.
Materials And Methods
This randomized double- blind clinical trial was designed to compare the efficacy of buprenorphine and pethidine in prevention of post anesthetic shivering. Sixty ASA grade I-II patients undergoing general anesthesia for elective Cesarean section entered the study. Patients received either buprenorphine 3mg/kg (n=30) or pethidine 0.5 mg/kg (n=30) intravenously 30 min before the end of surgery. Heart rate and blood pressure were measured 15 min after the injection. Occurrence of shivering was evaluated for one hour in the recovery room. Also, pain intensity was assessed by using a visual analog scale (VAS; 0-5).
Results
Shivering was significantly reduced in the pethidine group (5 of 30 versus 13 of 30, p<0.05). Visual pain scores were similar in both groups. There was no difference between the two groups regarding hemodynamics.
Conclusion
Despite similar in pain control, pethidine is more effective than buprenorphine in prevention of post anesthetic shivering. (Tanaffos 2007; 6(3): 54-58)
Language:
English
Published:
Tanaffos Respiration Journal, Volume:6 Issue: 3, Summer 2007
Page:
54
magiran.com/p589098  
دانلود و مطالعه متن این مقاله با یکی از روشهای زیر امکان پذیر است:
اشتراک شخصی
با عضویت و پرداخت آنلاین حق اشتراک یک‌ساله به مبلغ 1,390,000ريال می‌توانید 70 عنوان مطلب دانلود کنید!
اشتراک سازمانی
به کتابخانه دانشگاه یا محل کار خود پیشنهاد کنید تا اشتراک سازمانی این پایگاه را برای دسترسی نامحدود همه کاربران به متن مطالب تهیه نمایند!
توجه!
  • حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران می‌شود.
  • پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانه‌های چاپی و دیجیتال را به کاربر نمی‌دهد.
In order to view content subscription is required

Personal subscription
Subscribe magiran.com for 70 € euros via PayPal and download 70 articles during a year.
Organization subscription
Please contact us to subscribe your university or library for unlimited access!